QAX

Hemodialyzer With Expanded Solute Removal Profile

Product code
QAX
Device name
Hemodialyzer With Expanded Solute Removal Profile
Device class
Class 2
21 CFR
21 CFR 876.5862
Medical specialty
Gastroenterology, Urology
Marketing pathway
510(K)
Flag
Life-sustaining / life-supporting
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
2 (all years; only the last 3 years are listed here)

FDA classification definition

A hemodialyzer with expanded solute removal profile is intended for use as part of an artificial kidney system for the treatment of patients with renal failure by performing such therapies as hemodialysis, hemofiltration, and hemodiafiltration. A hemodialyzer with expanded solute removal profile includes modifications to the semipermeable membrane that allows for increased removal of uremic retention solutes compared with standard high-flux hemodialyzers of the high permeability hemodialysis system classification (21 CFR §876.5860), including solutes at the upper end of the “middle” molecular weight range (0.5 kDa to 60 kDa).

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-07-28.

NumberDecision dateApplicantDevice nameSummary
K2613992026-07-28Nipro Medical CorporationELISIO™-HXPDF

1 summaries are archived here for direct download.

Official FDA classification page: QAX
Classification and pathway per current FDA publications. Data from openFDA (CC0).